A study to understand the usefulness of Pix liquida (Homoeopathic medicine) for individuals suffering from alopecia areata (patchy baldness).

A study to evaluate the efficacy of Pix liquida for individuals suffering from alopecia areata

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/08/045128

Enrollment

Registered

2022-08-31

Start date

Unknown

Completion date

Unknown

Last updated

2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L639- Alopecia areata, unspecified

Interventions

Intervention1: Pix Liquida.: Homoeopathic Medicine. Duration of therapy-45 Days to 6 months. Mode of administration: Oral(Sublingual) Selection of potency, dose and repetition: Pix Liquida will be p

Eligibility

Inclusion criteria

Inclusion criteria: 1.)Pre-diagnosed Alopecia Areata cases 2.)Patients having no improvements from traditional treatments 3.)Cases present with all the variants of Alopecia Areata 4.)Patients seeking harmless remedial alternatives 5.)Patients that give consent for study and administration of homoeopathic treatment

Exclusion criteria

Exclusion criteria: 1.)Homoeopathic remedies except Pix Liquida 2.)Cases with advanced & severe pathology condition 3.)Cases with complications and co-morbid implications 4.)Patients not willing to give consent

Design outcomes

Primary

Measure	Time frame
Primary outcome is mainly assessed by severity of Alopecia tool score(SALT SCORE)Timepoint: 45 days to 6 Months	—

Secondary

Measure	Time frame
Secondary outcome is assessed by comparing the parameters before and after the treatment and Improvement in clinical symptomsTimepoint: 6 Months to 12 months	—

Countries

India

Contacts

Public ContactDrPuja S Dabhi

Parul University

tarun.das@paruluniversity.ac.in9426034324

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026